Genentech, Inc.South San Francisco, CA, United States (NYSE: DNA)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Genentech Cash Flow Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Quarter
Ending Jun 08		 Quarter
Ending Mar 08		 Quarter
Ending Dec 07		 Quarter
Ending Sep 07		 Quarter
Ending Jun 07
Net Operating Cash Flow 205.0 999.0 1,157.0 648.0 665.0
Net Investing Cash Flow 85.0 (416.0) (519.0) (994.0) (215.0)
Net Financing Cash Flow (682.0) 186.0 173.0 (11.0) (144.0)
Net Change in Cash (392.0) 769.0 811.0 (357.0) 306.0
Depreciation & Amortization 146.0 139.0 147.0 130.0 109.0
Capital Expenditures (198.0) (200.0) (285.0) (217.0) (266.0)
Cash Dividends Paid -- -- -- -- --
Data Definitions
Edgar Online logo
This data is provided as per license from EDGAR Online